Atrium Innovations uses Geocann’s VESIsorb for CBD delivery

June 5, 2019

Atrium Innovations is now using VESIsorb, a patented delivery system for improving ingredient absorption, for hemp cannabidiol (CBD) products in its healthcare-professional brands Pure Encapsulations, Douglas Laboratories, and Genestra Brands.

Atrium Innovations is now using VESIsorb, a patented delivery system for improving ingredient absorption, for hemp cannabidiol (CBD) products in its healthcare-professional brands Pure Encapsulations, Douglas Laboratories, and Genestra Brands. The brands are launching softgels featuring VESIsorb.

VESIsorb is existing, bioavailability-enhancing technology originally established more than a decade ago by ingredients company SourceOne Global Partners (Chicago). SourceOne’s founder Jesse Lopez recently founded a separate company called Geocann, which will use VESIsorb to develop CBD products. The company describes VESIsorb as “a naturally self-assembling colloidal droplet delivery system that has been well-recognized as the industry leader for improving the bioavailability of poorly absorbed natural ingredients, like cannabinoids and terpenes.

“As the industry hemp market continues to flourish, these product launches provide exceptional credibility to the therapeutic benefits of cannabinoids formulated with VESIsorb,” Lopez said in a press release.

Several Atrium Innovations brands have already used VESIsorb for ingredients like CoQ10, resveratrol, and vitamin D3. Dr. Andrew Halpner, Atrium’s vice president of science and technical services, added in the press release: “After a thorough due-diligence process to offer the best hemp products to our loyal customer base, we are extremely proud to expand our portfolio with another VESIsorb formulation…”